Presentation is loading. Please wait.

Presentation is loading. Please wait.

Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway.

Published byPauliina Hiltunen Modified over 5 years ago

Similar presentations

Presentation on theme: "Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway."— Presentation transcript:

1 Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation  Gaetano Prosperini, MDa, Kajakulasingam Rajakulasingam, MDb, Rossella R. Cacciola, MD, PhDc, Lucia Spicuzza, MDa, Steuart Rorke, MDb, Stephen T. Holgate, MDb, Giuseppe U. Di Maria, MDa, Riccardo Polosa, MD, PhDa  Journal of Allergy and Clinical Immunology  Volume 110, Issue 6, Pages (December 2002) DOI: /mai Copyright © 2002 Mosby, Inc. Terms and Conditions

2 Fig. 1 Changes in PC20 methacholine and PC20 AMP values expressed as mean ± SEM doubling dilutions after each 3-week treatment period with placebo (Pla ; open circles ) and budesonide (Bude ; filled circles ). *P < .05 and **P < .001 (after placebo vs after budesonide treatment). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2002 Mosby, Inc. Terms and Conditions

3 Fig. 2 Comparative changes in PC20 methacholine (filled circles) and PC20 AMP (open circles) values expressed as mean ± SEM doubling dilutions before, during, and after discontinuation of budesonide treatment. *P < .05, **P < .01, and ***P < .001 (after treatment vs baseline). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2002 Mosby, Inc. Terms and Conditions

4 Fig. 3 Comparative changes in median (± interquartile range) percentage of eosinophil (open boxes) and epithelial cell (filled boxes) counts in the sputum before, during, and after discontinuation of budesonide treatment. Medians are shown as thick horizontal bars . *P < .05 and **P < .01 (after treatment vs baseline). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2002 Mosby, Inc. Terms and Conditions

Download ppt "Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway."

Similar presentations

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor.

Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor.
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome  Paul Steinberg, MDa, Bruce E.

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome  Paul Steinberg, MDa, Bruce E.
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.

Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma  Makoto Hoshino, MDa, Yutaka Nakamura, MDa,

Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma  Makoto Hoshino, MDa, Yutaka Nakamura, MDa,
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin a- induced bronchoconstriction  Nunzio Crimi, MD, Corrado Pagano, MD,

Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin a- induced bronchoconstriction  Nunzio Crimi, MD, Corrado Pagano, MD,
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
The effect of omalizumab on nasal allergic inflammation

The effect of omalizumab on nasal allergic inflammation
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol  Ian D. Pavord, DM, FRCP, Peter K. Jeffery,

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol  Ian D. Pavord, DM, FRCP, Peter K. Jeffery,
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 
Pathophysiology of severe asthma

Pathophysiology of severe asthma
Inflammation of small airways in asthma

Inflammation of small airways in asthma
Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma  Annika Wallin, PhDa, Malcolm Sue-Chu, PhDb, Leif Bjermer,

Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma  Annika Wallin, PhDa, Malcolm Sue-Chu, PhDb, Leif Bjermer,
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis  Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis  Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

Similar presentations

Ads by Google